Cough and Multiple sclerosis

Summary:

Multiple sclerosis is found among people with Cough, especially for people who are female, 40-49 old.

The study analyzes which people have Multiple sclerosis with Cough. It is created by eHealthMe based on reports of 35 people who have Cough from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Cough?

Cough is found to be associated with 3,049 drugs and 3,801 conditions by eHealthMe. Check the latest studies of Cough.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,088 drugs and 1,361 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

On Jul, 16, 2026

35 people who have Cough and Multiple Sclerosis are studied.

Would you have Multiple sclerosis when you have Cough?

Gender of people who have Cough and experienced Multiple Sclerosis *:

female: 82.86 %
male: 17.14 %

Age of people who have Cough and experienced Multiple Sclerosis *:

Common co-existing conditions for these people *:

Headache (pain in head): 15 people, 42.86%
Weakness: 14 people, 40.00%
Asthma: 14 people, 40.00%
Sputum Discolored: 14 people, 40.00%
Oropharyngeal Pain: 14 people, 40.00%
Ear Pain: 14 people, 40.00%
Dyspnea (difficult or laboured breathing): 8 people, 22.86%
Nausea (feeling of having an urge to vomit): 8 people, 22.86%
Migraine (headache): 7 people, 20.00%
Stress And Anxiety: 7 people, 20.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Fatigue (feeling of tiredness): 20 people, 57.14%
Dyspnea (difficult or laboured breathing): 17 people, 48.57%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 15 people, 42.86%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 14 people, 40.00%
Sinus Congestion (blockage of sinus): 14 people, 40.00%
Dysstasia (difficulty in standing): 14 people, 40.00%
Chest Pain: 14 people, 40.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 14 people, 40.00%
Pulmonary Embolism (blockage of the main artery of the lung): 14 people, 40.00%
Respiratory Rate Increased (excess breathing rate/min): 14 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Multiple sclerosis?

- Check whether Multiple sclerosis is associated with a drug or a condition

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .

Related studies:

Treatments, associated drugs and conditions:

Cough (361,791 reports)
Multiple sclerosis (799,636 reports)

All the drugs that are associated with Multiple sclerosis:

Multiple sclerosis (1,088 drugs)

All the conditions that are associated with Multiple sclerosis:

Multiple sclerosis (1,361 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Multiple sclerosis and Cough, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.